Date	Period	Revenue/Estimate	Earnings Call
Aug 9, 2024	2025/Q1	1.000M / --	--
Aug 9, 2022	2023/Q1	2.000M / --	--
Feb 14, 2022	2022/Q3	2.000M / --	--
Aug 6, 2021	2022/Q1	2.000M / --	--
Feb 12, 2021	2021/Q3	1.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Aug 9, 20242025/Q11.000M / ----

Aug 9, 20222023/Q12.000M / ----

Feb 14, 20222022/Q32.000M / ----

Aug 6, 20212022/Q12.000M / ----

Feb 12, 20212021/Q31.000M / ----

Unlock Free Earnings Estimates

Open Account

Ribomic: Financial results briefing for the 2nd quarter (interim period) of the fiscal year ending 2025/3 (Q & A)

Nov 22 01:30 ET

Ribomic: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending 2025/3

Nov 20 04:00 ET

Ribomic: Confirmatory letter.

Nov 12 20:14 ET

Ribomic: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)

Nov 12 20:13 ET

Symbol Price % Chg

See the daily top gainer.